Skip to main content
Mark Frohlich, MD, Oncology, Seattle, WA

Mark Walter Frohlich MD


EVP R&D, Juno Therapeutics

Join to view full profile
  • 1951 E 120th StApt 2Seattle, WA 44106

  • Phone+1 206-744-3241

Dr. Frohlich is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Residency, Internal Medicine, 1990 - 1994
  • Harvard Medical School
    Harvard Medical SchoolClass of 1990

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 2002 - 2026

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • 18th Annual International Society for Cellular Therapy (ISCT) Meeting 
    International Society for Cellular Therapy, Seattle, Washington - 6/5/2012

Press Mentions

  • Register Now
    Register NowJuly 19th, 2024
  • NEUVOGEN Appoints Dr. Mark W. Frohlich, a World-Renowned Immunotherapy Expert to Its Board of Directors and Scientific Advisory Board
    NEUVOGEN Appoints Dr. Mark W. Frohlich, a World-Renowned Immunotherapy Expert to Its Board of Directors and Scientific Advisory BoardAugust 23rd, 2021
  • Survey: Hoosier Manufacturers Expect to Weather COVID Storm
    Survey: Hoosier Manufacturers Expect to Weather COVID StormNovember 19th, 2020

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: